Frank Steven bought BCRX
May 29, 2026 · Form 4 insider transaction
Frank Steven bought 1,262 shares of BioCryst Pharmaceuticals, Inc. at $8.91 per share, a transaction worth $11.2K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,262
Price
$8.91
Total value
$11.2K
InsiderFrank Steven
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateMay 29, 2026
Filing dateJune 2, 2026
Shares owned after20,165
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares of Common Stock issued to the reporting person in lieu of 100% of the quarterly cash Board Member retainer of $11,250.